EFPIA - NEWSLETTER

EFPIA Newsletter 21 March 2024

EFPIA signs the Antwerp Declaration

This week EFPIA signed the Antwerp Declaration. The declaration calls for a European Industrial Deal to drive the region’s competitiveness and resilience. In our sector, one of the most valuable strategic industries in the region, we have witnessed a 25% fall in the share of global R&D investment over the past two decades. Creating a new industrial deal for Europe could be the catalyst to prevent further decline and build a healthier, more competitive and resilient Europe. Hear more from David Loew, CEO at Ipsen and EFPIA second Vice-President and read our statement: https://bit.ly/3IO33qW

News

19 March 2024 EFPIA responds to ENVI adoption of the amendments to the Pharma-legislation

As MEPs vote on the amended text in the plenary session and discussions at the Council continue, EFPIA and its Members...

20 March 2024 Research based pharmaceutical industry calls on European Commission to develop comprehensive...

EFPIA response to the Commission’s Communication on Boosting Biotechnology and Biomanufacturing in the EU

Building a Healthier Tomorrow: The Role of Medical Innovation in the EU

What’s the role of medical innovation in the EU? Watch this interview with Roberta Savli, Executive Director, Public Affairs at EFPIA, to find out more.

Have you missed our latest webinar? Watch the recording!

Regulatory Reliance Tools Unveiled: A Practical Guide by EMA

Learn more about EMA’s assessment process and how it can be leveraged for reliance.

What we are reading

ERT 2024 Benchmarking Report 18 March 2024 (ERT)

CVD+D: Why the EU needs a comprehensive cardiovascular-diabetes health plan 18 March 2024 (Euractiv)

Special issue of journal highlights impacts of IMI and IHI projects on Alzheimer’s disease 11 March 2024 (IHI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶